Skip to Main ContentSkip to FooterSkip to Search
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Gene Therapy
  6.  » Put your AAV on the Fast-Track to the Clinic

Put your AAV on the Fast-Track to the Clinic

Summary:​ In this executive summary, Catalent Cell & Gene Therapy experts George Buchman, Ph.D., Research Fellow, and Bhargavi Kondragunta, Ph.D., Director, Internal R&D and Product Development, explain Catalent’s approach to fast-tracking AAVs through a platform approach that is consistent and scalable, along with providing clients with Catalent’s clonal cell-line and off-the-shelf plasmids for a one-stop integrated solution. The authors provide a blueprint for a complete platform approach, enabling a process that easily scales as the project progresses to late-stage GMP production and to market.​

Read the Executive Summary